Characterization of the transportation of berberine in Coptidis rhizoma extract through rat primary cultured cortical neurons

被引:20
作者
Chen, Yunyun [1 ]
Wang, Xueli [1 ]
Sun, Hong [2 ,3 ]
Xing, Dongming [1 ]
Hu, Jun [1 ]
Wai, Zhuohan [1 ]
Du, Lijun [1 ]
机构
[1] Tsinghua Univ, Dept Biol Sci & Biotechnol, Lab Pharmaceut Sci, Beijing 100084, Peoples R China
[2] Tsinghua Univ, Chinese Acad Med Sci, Inst Med Plant, Beijing 100094, Peoples R China
[3] Tsinghua Univ, Peking Union Med Coll, Beijing 100094, Peoples R China
关键词
berberine; cortical neuron; transportation; HPLC;
D O I
10.1002/bmc.889
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The aim of this study was to investigate the transport behavior and efflux of berberine through the primary culture cortical neurons. High-performance liquid chromatography coupled with an UV-vis detector at 347 nm was applied. The mobile phase was 0.05 m potassium dihydrogen phosphate solution (containing 0.5% triethylamine, pH 3.0)-acetonitrile (73:27, v/v). Neurons were incubated with Coptidis rhizoma extract 6.5 mu g/mL (containing 1.91 mu g/mL berberine) and verapamil, KCN or cimetidine for 2 h, and then lysed in methanol to extract intracellular berberine. A 20 mu l aliquot of sample was injected into the HPLC system to determine berberine concentration. The results showed that metabolic inhibitor KCN and P-glycoprotein inhibitor verapamil could increase berberine concentration within the neurons, indicating that efflux of berberine was energy-dependent and P-glycoprotein was likely to be involved. Moreover, the organic cation transporter inhibitor cimetidine could decrease berberine concentration within the neurons, suggesting that the organic cation transporter might be involved in the berberine transport process. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:28 / 33
页数:6
相关论文
共 30 条
[1]
BOVA S, 1992, J PHARMACOL EXP THER, V261, P318
[2]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]
CHIOU WF, 1991, EUR J PHARMACOL, V204, P35
[4]
KACZOROWSKI S, 1991, Patologia Polska, V42, P119
[5]
Vasorelaxant and antiproliferative effects of berberine [J].
Ko, WH ;
Yao, XQ ;
Lau, CW ;
Law, WI ;
Chen, ZY ;
Kwok, W ;
Ho, K ;
Huang, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 399 (2-3) :187-196
[6]
BERBERINE COMPLEXES WITH DNA IN THE BERBERINE-INDUCED APOPTOSIS IN HUMAN LEUKEMIC HL-60 CELLS [J].
KUO, CL ;
CHOU, CC ;
YUNG, BYM .
CANCER LETTERS, 1995, 93 (02) :193-200
[7]
Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine [J].
Marinova, EK ;
Nikolova, DB ;
Popova, DN ;
Gallacher, GB ;
Ivanovska, ND .
IMMUNOPHARMACOLOGY, 2000, 48 (01) :9-16
[8]
Mirska I, 1972, Arch Immunol Ther Exp (Warsz), V20, P921
[9]
NOBUKAZU S, 2007, BIOSCIENCE BIOTECHNO, V71, P1
[10]
PAN LX, 1997, CHINESE J EXPT SURG, V14, P254